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Objective: To evaluate how young physicians in
training perceive their patients’ cardiovascular risk
based on the medical charts and their clinical judg-
ment.
Design: Cross sectional observational study.
Setting: University outpatient clinic, Lausanne,
Switzerland.
Subjects: Two hundred hypertensive patients
and 50 non-hypertensive patients with at least one
cardiovascular risk factor.
Main outcome measure: Comparison of the
absolute 10-year cardiovascular risk calculated by
a computer program based on the Framingham
score and adapted for physicians by the WHO/
ISH with the perceived risk as assessed clinically
by the physicians.
Results: Physicians underestimated the 10-year
cardiovascular risk of their patients compared to
that calculated with the Framingham score. Con-
cordance between methods was 39% for hyper-
tensive patients and 30% for non-hypertensive
patients. Underestimation of cardiovascular risks
for hypertensive patients was related to the fact
they had a stabilized systolic blood pressure under
140 mm Hg (OR = 2.1 [1.1; 4.1]). 
Conclusions: These data show that young physi-
cians in training often have an incorrect percep-
tion of the cardiovascular risk of their patients with
a tendency to underestimate the risk. However, the
calculated risk could also be slightly overestimated
when applying the Framingham Heart Study
model to a Swiss population. To implement a sys-
tematic evaluation of risk factors in primary care a
greater emphasis should be placed on the teaching
of cardiovascular risk evaluation and on the imple-
mentation of quality improvement programs.
Key words: hypertension; cardiovascular risk
Blood pressure levels, both systolic and dias-
tolic, have been shown to be positively and linearly
related to the risks of stroke, coronary heart dis-
ease, heart failure and renal disease [1]. According
to several national and international guidelines,
the management of patients with hypertension
should be based on the absolute cardiovascular risk
of patients rather than on the level of blood pres-
sure alone [2–5]. An estimation of the individual
cardiovascular risk should take into account 
several risk factors such as age, gender, smoking,
diabetes, cholesterol, family history of premature
cardiovascular disease, the presence of target
organ damage and history of cardiovascular and
renal diseases [2].
Previous studies demonstrated that risk assess-
ment performed by a small group of senior hyper-
tension specialists as well as general practitioners
is poor, has a bad concordance with the calculated
risk and is poorly reproducible [6, 7]. To improve
physicians’ ability to accurately predict cardio-
vascular risk in their patients, appropriate tables
and computer programs have been developed [3,
8–11]. Nevertheless, these tools are generally un-
derused in clinical settings because they are either
not available or difficult to use and time-consum-
ing in a consultation. Hence, the assessment of car-
diovascular risk remains a difficult task for most
doctors, who generally rely on their own intuitive
appreciation of the risk. A large German survey
(11,547 physicians contacted) has recently sug-
gested that hypertension guideline awareness is
better among newly qualified physicians [12].
Thus, young doctors in a teaching environment
may be more aware of the present recommenda-
tions and might be more accurate in predicting the
cardiovascular risk of their patients. Yet, to our
knowledge, the ability of young physicians in train-
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ing to judge the 10-year cardiovascular risk of their
hypertensive patients, as recommended in most
hypertension management guidelines, has never
been assessed.
Therefore, the goal of this study was to evalu-
ate how young doctors in training perceive the 10-
year cardiovascular risk of their patients and to
compare their assessment with the absolute risk
calculated by a computer program using the Fram-
ingham score adapted by the WHO-ISH guide-
lines for physicians. Thereafter, we have examined
potential determinants of a discrepancy between
the calculated risk and the physician’s perception
in hypertensive patients. 
Methods and subjects
Patients
Two hundred hypertensive patients followed during
the investigation period (from June 2001 to August 2001)
by the clinical residents of the University Outpatient
Clinic in Lausanne were included in this study. Subjects
were selected by viewing all the files in each physician’s of-
fice (all patients under treatment). All patients were in-
cluded until the predetermined sample size was achieved.
The sole inclusion criteria were that patients had to be hy-
pertensive, to receive an antihypertensive therapy and that
the medical charts were complete. To estimate the capac-
ity of physicians to evaluate the cardiovascular risk of pa-
tients with known risk factors other than high blood pres-
sure (BP), the same recruiting method was used to select
fifty non-hypertensive patients with at least one cardio-
vascular risk factor such as smoking, dyslipidaemia or
diabetes.
Physicians
Seventeen physicians (8 men and 9 women), all work-
ing at the university medical outpatient department in
Lausanne, participated in this study with their given con-
sent. Their mean age was 32 years (range: 26–43 years).
Their mean duration of post-graduate training was about
5 years (range 1 to 9) with a mean of 2.5 years in internal
medicine (range 1–5). When evaluating the risk of their
patients, physicians had access to their patient’s records
but they had no access to computer programs or tables
enabling to calculate the risk. Moreover, no particular
training on risk estimation was provided before starting
the study.
Methods
All medical charts were reviewed by a single investi-
gator (MS) to verify that the key elements necessary to cal-
culate the cardiovascular risk according to the Framing-
ham equation were present in the charts. These included
blood pressure (mean of the last 3 measurements), gender,
age, total cholesterol, blood glucose, body weight and
height, smoking habits and a complete personal and famil-
ial cardiovascular history. The data of each patient were
reported on a questionnaire and included in a database in
order to calculate the individual cardiovascular risk as
reported in the 1999 WHO-ISH guidelines [13] and
discussed in European guidelines [2]. Thereafter, the car-
diovascular risk was calculated for each individual accord-
ing to the Framingham score developed in 1998 in the
Framingham Heart Study. The heterogeneity of patients
followed in the outpatient clinic (more than 50% were
non-Swiss patients) justified the use of the Framingham
score rather than Swiss scores to calculate the risk of this
group of patients. Each doctor was interviewed personally
and was asked to attribute a 10-year cardiovascular risk to
their patients using one of the four categories described in
the WHO-ISH guidelines i.e.: low risk <15%, medium
risk 15–20%, high risk 20–30% and very high risk >30%.
Statistical analysis
We adopted a descriptive approach without any
statistical inference to describe case and control groups as
different sampling fractions were used. Results where
considered concordant when both computer and physi-
cian assign the same risk category. 
For hypertensive patients, predictors for underesti-
mation of risk versus correct or overestimation were ana-
lyzed by a random effects logistic regression model. A
multivariable model was constructed using clinically log-
ical grounds based on known predictors of cardiovascular
risks. These were: having a systolic blood pressure below
140 mm Hg, being a woman, being under 50 years old,
being treated for dyslipidaemia or having high LDL blood
level, having diabetes, being a non-smoker, having a
personal history of coronary heart disease and having a
positive family history of cardio-vascular diseases. We also
included the physician as a random effect in the model to
take account of any clustering effect. This random effect
logistic regression model was fit in Stata 8.2 (using the 
xtlogit function) and adjusted odds ratios (OR) are given
with a 95% confidence interval (CI).
Results
Two hundreds patients with hypertension fol-
lowed by 15 physicians were included in the analy-
sis. Number of patients per physician ranged from
1 to 23 with a median of 13. The 50 files from pa-
tients without hypertension were reviewed by 8
physicians (range 1 to 9; median 7). Table 1 shows
the characteristics of both groups of patients
included in the study. In the treated hyperten-
sive population (n = 200), 57% had a diastolic BP
<90 mm Hg (mean of the 3 last measurements at
different terms), 49% had a systolic BP <140 mm
Hg and 38% had a BP below 140/90 mm Hg. 
There was a clear underestimation by physi-
cians of the 10 year cardiovascular risk of their pa-
tients for both groups (figure 1). 78/200 (39%) of
patients were assigned in the same risk category
with both methods. Physicians underestimated
risk category for 48% of hypertensive patients
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compared to the Framingham score, and overesti-
mated it for 13% (table 2). 
Where risk was underestimated in known hy-
pertensive patients (n = 96), the underestimation
was of one category in two thirds of the patients
and of two categories or more in one third of the
cases. Of patients with an actual measured BP
>140/90 mm Hg (n = 104), the physician underes-
timated risk, correctly assessed risk and overesti-
mated risk in 39%, 44% and 17% of patients re-
spectively.
Logistic regression analysis with physicians as
a random effect, showed no evidence of between-
physician variability. Multivariate model (table 3)
reveals that underestimation of risk is related to
having a normalized systolic BP (OR = 2.1 [1.1;
4.1]). In non-hypertensive subjects, 30% of the
assessments were concordant between methods,
54% were underestimated by physicians and 16%
overestimated. 
Hyper- Non-
tensive hypertensive 
(n = 200) (n = 50)
Men: N (%) 121 (60%) 30 (60%)
Dyslipidaemia: N (%) 138 (68%) 27 (54%)
Diabetes: N (%) 69 (34%) 4 (8%)
Smoker: N (%) 54 (27%) 29 (58%)
Family history of coronary heart 27 (13%) 4 (8%)
disease: N (%)
Age (years): mean (SD) 63 (14) 47 (16)
BMI (kg/m2): mean (SD) 28 (5) 27 (6)
Systolic BP (mm Hg): mean (SD) 141 (19) 128 (13)
Diastolic BP (mm Hg): mean (SD) 86 (11) 81 (7)
BP: blood pressure, BMI: body mass index
Table 1
Characteristics of
included hyperten-
sive (n = 200) and
non-hypertensive
patients (n = 50).
Figure 1
Distribution of the
physician-perceived
and computer-calcu-
lated cardiovascular
risk in 200 hyper-
tensive and 50 non-
hypertensive
patients.
Framingham’ score
Low Moderate High Very high
(<15%) (15–20%) (21–30%) (>30%)
Physicians’ estimation
Low (<15%)
Hypertensive (n = 200) / non-hypertensive (n = 50) 4 / 0 12 / 19 13 / 3 5 / 0
Moderate (15–20%)
Hypertensive (n = 200) / non-hypertensive (n = 50) 5 / 0 11 / 6 24 / 2 14 / 0
High (21–30%)
Hypertensive (n = 200) / non-hypertensive (n = 50) 0 / 0 11 / 4 29 / 7 28 / 5
Very high (>30%)
Hypertensive (n = 200) / non-hypertensive (n = 50) 0 / 0 1 / 0 9 / 2 34 / 2
Table 2
Concordance be-
tween physicians’
and Framingham es-
timation of risk cate-
gory for both hyper-
tensive (n = 200) 
and non-hyperten-
sive patients (n = 50).
N
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<15% 15–20% 20–30% >30%
Level of risk
<15% 15–20% 20–30% >30%
Level of risk
Hypertensive patients 
(n = 200)
Non-hypertensive patients 
(n = 50)
Physicians’ estimation
Framingham Score
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In recent years, several national and interna-
tional guidelines have proposed to assess the global
risk of hypertensive patients in order to take ther-
apeutic decisions [2–4, 13]. The results of the pres-
ent study show that the judgment of young physi-
cians of the 10-year cardiovascular risk of their pa-
tients is relatively poor when compared to a com-
puter-calculated risk. Indeed, almost 50% of the
assessments were underestimated and close to 15%
were overestimated. Multivariate analysis showed
that hypertensive patients with an underestimated
risk were more likely to have a lower blood pres-
sure. 
So far, very few studies have examined the abil-
ity of physicians to predict accurately the cardio-
vascular risk of their hypertensive patients. In one
study, the ability of six senior hypertensive special-
ists was investigated and the results of this study
showed that only three of these specialists were in
keeping with Framingham predictions [6]. In a
larger French study, 953 general physicians esti-
mated the absolute risk of 1243 hypertensive pa-
tients. Their estimation was then compared to a
calculated risk. The concordance between the es-
timated and the calculated risk was 35% with 50%
underestimation [7]. Our finding agrees with this
observation with 48.5% underestimation in the
hypertensive group and 54% underestimation in
the non-hypertensive control group. Yet, our re-
sults differ from those reported previously by
Grower et al. in which doctors tended to systemat-
ically overestimate the absolute risk of coronary
heart disease in individual patients [14]. However,
in this latter study, hypothetical patients were pre-
sented and physicians attended several meetings
before participating in the study [14]. In contrast,
in the present study, physicians were younger and
were asked to assess the risk of their own patients.
Hanon et al, who studied only patients with a
BP greater than 140/90 mm Hg found that correct
estimation of the risk was predicted by being a
man, being a smoker and having a low HDL cho-
lesterol [7]. In their hands blood pressure per se
had no impact on the prediction. In contrast our
study shows that blood pressure has an impact on
the physician’s perception of the cardiovascular
risk. Thus we found that treated hypertensive pa-
tients with a low systolic blood pressure are 2.5
times more likely to have their cardiovascular risk
underestimated compared to the computer calcu-
lated risk. The observed trend concerning differ-
ent risk assessments between smokers and non-
smokers may be due to the fact that smokers’ risks
are better evaluated [7]. In this respect, training of
residents in tobacco prevention programs could
explain their capacity to assess more accurately the
cardiovascular risk of smoking patients [15].
In this study, the computer-calculated risk was
taken as the reference system. The computer cal-
culation was based on the WHO-ISH guidelines
[13] which provide a simple method to calculate
the combined effect of several risk factors and con-
ditions on the future absolute risk of major cardio-
vascular events. These calculations are based on
data from the Framingham study [16]. When used
in our population, it is possible that the computer
calculation overestimates the risk. Thus, for exam-
ple, in our control group, young smoking males
(below age 30) were often attributed a 15–20% risk
of cardiovascular complications over 10 years by
the computer whereas physicians tended to give a
lower estimate. In this situation, physicians may be
closer to the truth because the computer assess-
ment does not take into account other variables
such as the number of cigarettes smoked each day
[15]. One may also argue that the Framingham risk
function is not appropriate for a central European
population and that it overestimates the risk of our
patients. Nevertheless, recent studies have sug-
gested that Framingham data are accurate for
northern European populations [17] but this may
not be true for all European populations [18]. Lau-
rier et al. have demonstrated that the Framingham
data overestimate the coronary heart disease risk
in the French population [19], Thomsen et al. have
drawn the same conclusion in the Danish popula-
tion [20] and Menotti et al. for the Italian popula-
tion [21]. A prospective cohort study showed that
N (%) with Adjusted OR
underestimated risk [95% CI]
Gender (Women versus men) 43 (54%) vs. 53 (44%) 1.8 [0.9; 3.5]
Age (950 y versus >50 y) 18 (56.3%) vs. 77 (48.4%) 1.2 [0.5; 3.0]
Controlled Blood Pressure 58 (56%) vs. 38 (39%) 2.1 [1.1; 4.1]*
(Systolic BP <140 versus 0140 mm Hg)
Smoking habits (Non-smoker versus smoker) 78 (52%) vs. 18 (36%) 2.0 [0.9; 4.4]
Dyslipidaemia (LDL >6.5 mmol or treated versus other) 66 (48%) vs. 30 (47%) 0.9 [0.4; 1.9]
Diabetes (diabetes versus no diabetes) 33 (49%) vs. 63 (47%) 0.7 [0.3; 1.5]
Personal history of coronary heart disease (With versus none) 24 (48%) vs. 72 (49%) 1.3 [0.6; 3.0]
Family history of coronary heart disease (With versus none) 15 (62%) vs. 81 (46%) 2.0 [0.7; 5.9]
* Adjusted OR significantly different from 1 with CI 95%
Table 3
Odds ratios of under-
estimating cardio-
vascular risks versus
not underestimating
them on usual pre-
dictors for hyperten-
sive patients. Logistic
regression model
was clustered for
physicians (n = 200). 
Discussion
S W I S S  M E D  W K LY 2 0 0 6 ; 1 3 6 : 6 0 3 – 6 0 8  ·  w w w. s m w. c h 607
overestimation of Framingham functions concerns
mainly patients in the highest risk quintile and that
it ranged from 2% in UK to 7% in France [22].
However, our results showed that patients with
lower risk factors were those whose cardiovascular
risks tended to be most underestimated. Achieving
proper assessment without computed database can
be difficult especially for heterogeneous popula-
tions. For this reason, alternative databases are ac-
cessible where the risk of other populations can be
calculated, for example based on the data obtained
in European population (www.scopri.ch/MONI-
CA-PROCAM3_RA3.html). One other limitation
of our study is that our hypertensive patients were
treated and whether risk assessment is still valid in
treated hypertensive patients has been discussed
earlier [22]. However, if lowering blood pressure
with a therapy in order to reduce the patient’s car-
diovascular risk, had no impact on the estimation
of the total cardiovascular risk, the entire validity
of the risk calculation should be questioned. More-
over, the Framingham risk function uses a model
which takes into consideration the fact that pa-
tients are treated.
In conclusions, our data confirm that even
though guidelines exist for targeting patients at
high risk of cardiovascular diseases, an accurate as-
sessment of coronary risk in hypertensive patients
remains a difficult task for doctors. This is true
even in a teaching hospital where doctors have free
access to computers and to the latest medical in-
formation and have direct contacts with specialists.
However, one has to emphasize that in many
teaching hospitals young physicians are not read-
ily trained to improve their ability to assess the risk
of their patients because educational interventions
are lacking. Consequently, doctors tend to overes-
timate their own capacity to assess cardiovascular
disease risk factors [23]. The use of tables and
computer-based programs should enhance their
abilities to assess the cardiovascular risk. Several
studies have indeed suggested that a computer-
based evaluation of the risk has a favourable impact
on physicians [8–11] but it appears to have only a
minor impact on patient management and its 
effect on the quality of blood pressure control is
still questioned [24]. If one wishes to implement a
systematic evaluation of risk factors in primary
care a greater emphasis should be placed on the
teaching of cardiovascular risk evaluation and on
the implementation of quality improvement pro-
grams.
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